Short answer: Mitragynine pseudoindoxyl is a naturally occurring metabolite formed through the oxidation and molecular rearrangement of kratom alkaloids. Early laboratory research suggests it has an exceptionally high affinity for certain receptors in the body, making it one of the most pharmacologically interesting compounds discovered in the kratom family. While the science is exciting, human research is still in its infancy, and consumers should approach products marketed as “Pseudo” with care.
If you hang in kratom circles, you’ve probably come across the term, mitragynine pseudoindoxyl. You’ll sometimes see it called, “Pseudo” or “Pseudo 7-OH.” While this alkaloid metabolite is generating genuine excitement in the pharmacology world, it’s actually one of the least understood compounds currently being discussed in the botanical space. That’s why we’re here: to hash out what we know and what we don’t know about Pseudo.
The Chemical Lineage: How Mitragynine Becomes Pseudoindoxyl
To understand mitragynine pseudoindoxyl, it helps to understand the chemical family tree.
The primary alkaloid found in kratom leaves is mitragynine. Although it’s the most abundant alkaloid in the plant, it isn’t necessarily the most pharmacologically active. Once consumed, a small portion of mitragynine is converted through metabolism into 7-hydroxymitragynine (7-OH). That conversion has been the focus of significant research, because 7-OH demonstrates substantially greater activity at the body's receptors than mitragynine itself. For years, many researchers viewed that as the end of the story … but it wasn't.
Additional laboratory research revealed that 7-hydroxymitragynine can undergo further oxidation and molecular rearrangement, producing an entirely different structure known as mitragynine pseudoindoxyl. Chemists refer to this transformation as the formation of a spiro-pseudoindoxyl scaffold, a structural change that dramatically alters how the molecule interacts with biological receptors. It’s an elegant (and pretty cool!) example of how relatively small chemical changes can produce surprisingly different pharmacological behavior.
That doesn’t mean your body is flooded with pseudoindoxyl every time you consume kratom or 7-OH. Researchers are still working to understand exactly how much Pseudo forms under various conditions and what role it ultimately plays in the overall user experience. But it does mean that kratom chemistry is considerably more complex than many people realize.
Why Researchers Are Paying Attention
Early laboratory studies suggest that mitragynine pseudoindoxyl binds extremely strongly to the same receptor responsible for many of the effects associated with other kratom alkaloids. That finding immediately attracted attention because receptor affinity often provides clues about biological activity. It’s also why you’ll frequently see pseudoindoxyl described online as being “stronger than 7-OH.”
There’s an important caveat, though. Laboratory potency doesn’t automatically translate into predictable human effects. (Humans, amirite?) Receptor binding is only one piece of a much larger puzzle that includes metabolism, bioavailability, individual physiology, dosage, and countless other variables. So, there’s more work to be done by the folks in the lab coats before we have a complete picture.
Pseudoindoxyl vs. 7-OH: What's the Difference?
Although 7-OH and Pseudo are chemically related, they aren’t interchangeable. 7-Hydroxymitragynine is a naturally occurring kratom alkaloid that has become widely recognized because of its potency relative to mitragynine. Mitragynine pseudoindoxyl, by contrast, is a downstream metabolite with a different molecular architecture. That altered structure appears to change how it interacts with receptors and other signaling pathways.
Researchers are actively studying whether those structural differences could eventually translate into meaningful therapeutic advantages, but it’s far too early to draw firm conclusions. For consumers, the practical takeaway is simple. Pseudoindoxyl shouldn't be viewed as “just a stronger version of 7-OH.” It’s an entirely different compound with its own pharmacological profile, much of which remains under investigation.
Could Pseudoindoxyl Lead to Slower Tolerance?
One of the more intriguing areas of research has little to do with potency. Instead, it focuses on how pseudoindoxyl activates cellular signaling pathways. Several preclinical studies suggest the compound may recruit β-arrestin-2 differently than many related compounds. That matters because β-arrestin signaling has been linked to respiratory depression and the development of tolerance.
Some animal studies have suggested that mitragynine pseudoindoxyl may produce less behavioral tolerance over time than expected for a compound with its receptor activity. It’s a fascinating observation, but it remains exactly that. Animal research often generates promising hypotheses that later change as human research develops. At present, there just isn’t sufficient clinical evidence to conclude that pseudoindoxyl produces slower tolerance in people.
Marketing Alert!
The last two topics sometimes get misrepresented by overzealous marketers. If you see a brand claiming that Pseudo is “stronger than 7-OH” or “develops a slower tolerance level,” keep in mind what we’ve already said: the science is all still out in front of us, so claims like that aren’t backed by sufficient research.
In fact, with our Orange Citrus 7-Hydroxy + Pseudo Tablets, we actually tell people the opposite. We don’t claim the Pseudo adds some super-buzz to the mix, but instead advise consumers to expect a more rounded experience than with our 7OH-only tabs. Our team has found that the Pseudo adds a subtle, balanced effect to the mix. So, believe us when we say to ignore the hype.
Navigating the “Wild West” of Pseudo Products
As often happens with emerging ingredients, commercialization has arrived faster than standardization. Today, you’ll find products marketed under names like Pseudo, Pseudo 7-OH, Mitragynine pseudoindoxyl tablets, and Advanced kratom alkaloid blends. Some of those names are representative of what’s inside the product, but some are a little sketchy. That’s why it’s important to look for a third-party lab test for your kratom product, called a Certificate of Analysis (COA). This test will tell you exactly what alkaloids are in your product and in what amount. They’ll also alert you if any contaminants are present. If your Pseudo or 7-OH product doesn’t come with a COA, don’t buy that product.
A Word of Caution
The excitement surrounding mitragynine pseudoindoxyl is understandable. It represents one of the most interesting discoveries in modern kratom chemistry and may eventually help researchers better understand how different alkaloids interact with the body’s receptor systems.
At the same time, today’s evidence base is still limited. There are no large human clinical trials establishing its long-term safety profile, ideal serving ranges, or comparative effects. Much of what appears online today blends legitimate science with speculation.
For consumers, that’s a reminder to stay curious, but also cautious. The newest compound isn’t automatically the best understood.
Frequently Asked Questions About Mitragynine Pseudoindoxyl
What Is Mitragynine Pseudoindoxyl?
Mitragynine pseudoindoxyl is a metabolite formed through the oxidation and molecular rearrangement of kratom alkaloids. It has become a significant topic of research because of its unique chemical structure and strong activity in preclinical laboratory studies.
Is Mitragynine Pseudoindoxyl Stronger Than 7-OH?
Early laboratory studies suggest pseudoindoxyl has a very high affinity for certain receptors. However, laboratory potency doesn’t necessarily predict human experience, and there are currently no clinical studies proving it produces stronger effects in people than 7-OH.
Is Pseudoindoxyl Naturally Found in Kratom?
Pseudoindoxyl is generally understood to form through metabolic and oxidative processes involving mitragynine and 7-hydroxymitragynine rather than existing as a major, naturally occurring alkaloid in fresh kratom leaves.
What Does “Pseudo 7-OH” Mean?
“Pseudo 7-OH” is primarily a marketing term used by some manufacturers. The actual compound being referenced is typically mitragynine pseudoindoxyl, which is chemically distinct from 7-hydroxymitragynine despite being related through metabolism. That’s why we add the “plus” sign in the name of our Pseudo product, Orange Citrus 7-Hydroxy + Pseudo Tablets: because it contains both 7-OH and Pseudoindoxyl.
Does Mitragynine Pseudoindoxyl Build Tolerance More Slowly?
Some animal studies have suggested that pseudoindoxyl may recruit β-arrestin-2 differently than similar compounds, leading researchers to investigate whether tolerance develops differently. Human clinical research has not yet confirmed this possibility.
Are Pseudoindoxyl Products Safe?
There isn't enough human research to make definitive conclusions about safety. Anyone considering products marketed as containing pseudoindoxyl should purchase only from reputable manufacturers that provide current third-party Certificates of Analysis and transparent ingredient testing.
____________________________________________________________________________
References
-
Váradi A, Marrone GF, Palmer TC, et al. Mitragynine/Corynantheidine Pseudoindoxyls as Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2. Journal of Medicinal Chemistry. 2016;59(18):8381-8397. Available at: https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00748
-
Kruegel AC, Uprety R, Grinnell SG, et al. 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects. ACS Central Science. 2019;5(6):992-1001. Available at: https://pubs.acs.org/doi/10.1021/acscentsci.9b00141
-
National Institute on Drug Abuse (NIDA). Kratom. National Institutes of Health. Available at: https://nida.nih.gov/research-topics/kratom
-
World Health Organization Expert Committee on Drug Dependence. Pre-Review Report: Kratom (Mitragyna speciosa), Mitragynine and 7-Hydroxymitragynine. 44th ECDD. Available at: https://cdn.who.int/media/docs/default-source/controlled-substances/unedited--advance-copy-44th-ecdd-review-report_kratom.pdf


